SBC
Income statement / Annual
Last year (2024), SBC Medical Group Holdings Incorporated's total revenue was $205.42 M,
an increase of 6.13% from the previous year.
In 2024, SBC Medical Group Holdings Incorporated's net income was $46.61 M.
See SBC Medical Group Holdings Incorporated,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
| Operating Revenue |
$205.42 M |
$193.54 M |
$174.16 M |
| Cost of Revenue |
$49.37 M
|
$56.24 M
|
$59.33 M
|
| Gross Profit |
$156.05 M
|
$137.30 M
|
$114.83 M
|
| Gross Profit Ratio |
0.76
|
0.71
|
0.66
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$67.31 M
|
$66.23 M
|
$93.48 M
|
| Selling & Marketing Expenses |
$2.78 M
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$70.09 M
|
$66.23 M
|
$93.48 M
|
| Other Expenses |
$15.66 M
|
$409.03 K
|
$1.23 M
|
| Operating Expenses |
$85.75 M
|
$66.64 M
|
$94.72 M
|
| Cost And Expenses |
$135.11 M
|
$122.88 M
|
$154.04 M
|
| Interest Income |
$19.94 K
|
$86.75 K
|
$472.38 K
|
| Interest Expense |
$28.30 K
|
$45.29 K
|
$31.44 K
|
| Depreciation & Amortization |
$3.80 M
|
$12.25 M
|
$5.93 M
|
| EBITDA |
$77.28 M |
$85.87 M |
$29.64 M |
| EBITDA Ratio |
0.38
|
0.44
|
0.17
|
| Operating Income Ratio |
0.34
|
0.37
|
0.12
|
| Total Other Income/Expenses Net |
$3.15 M
|
$2.92 M
|
$3.56 M
|
| Income Before Tax |
$73.46 M
|
$73.58 M
|
$23.68 M
|
| Income Before Tax Ratio |
0.36
|
0.38
|
0.14
|
| Income Tax Expense |
$26.77 M
|
$35.02 M
|
$18.12 M
|
| Net Income |
$46.61 M
|
$39.37 M
|
$6.32 M
|
| Net Income Ratio |
0.23
|
0.2
|
0.04
|
| EPS |
0.4827 |
0.418 |
0.0367 |
| EPS Diluted |
0.4827 |
0.418 |
0.0367 |
| Weighted Average Shares Out |
$96.56 M
|
$94.19 M
|
$15.07 M
|
| Weighted Average Shares Out Diluted |
$96.56 M
|
$94.19 M
|
$15.07 M
|
| Link |
|
|
|
